In the previous issue of Critical Care, Derwall and colleagues [1] reported on the eff ects of gaseous hydrogen sulfi de (H 2 S) (100 to 300 parts per million) in healthy, anesthetized, and mechanically ventilated sheep. To avoid any airway irritation, the authors used an elegant approach to circumvent inhaling H 2 S (that is, administration via an extracorporeal, veno-arterial membrane oxygenator). Th e major fi ndings were that (a) whole body oxygen uptake (VO 2 ), carbon dioxide production (VCO 2 ), and cardiac output remained within the physiological range but that (b) H 2 S caused pulmonary vasocon striction, which was (c) associated with a fall in blood pressure and metabolic acidosis at the highest doses administered.
In a landmark paper, Blackstone and colleagues [2] demonstrated that, in awake, spontaneously breathing mice, inhaling H 2 S induced a hibernation-like metabolic state characterized by reduced energy expenditure and hypothermia. Subsequently, Volpato and colleagues [3] reported that this metabolic depression was associated with bradycardia and reduced cardiac output but that blood pressure and stroke volume remained unaff ected. Consequently, given the exciting prospect of pharma cologically reducing energy expenditure to protect against ischemia ('suspended animation' [2] ) by application of a gaseous drug, the eff ects of inhaled H 2 S were investigated in various models. In fact, inhaled H 2 S protected rodents against other wise lethal hypoxia [4] and hemorrhage [5] and attenuated murine kidney and lung injury [6] [7] [8] . Equivocal data, however, are available from large animals: inhaled H 2 S failed to show any metabolic eff ect in sheep or swine [9, 10] , and the intravenous H 2 S donor sodium sulfi de (Na 2 S) was reported either to reduce energy expenditure [11] or to have no eff ect at all [12] .
What do we learn from the study by Derwall and colleagues [1] ? Th e authors confi rm previous data in the same species [9] that even a fi vefold-higher concentration of inhaled H 2 S did not depress energy expenditure. Since the authors maintained the body temperature, they speculate that in larger species H 2 S can hardly aff ect metabolism at all beyond the eff ect of temperature per se (the 'Q10 eff ect': the fall of VO 2 and VCO 2 associated with a 10°C decrease), in particular when metabolism is already depressed. In fact, in anesthetized and mecha nically ventilated mice subjected to deliberate hypothermia, inhaled H 2 S had no further metabolic and circulatory eff ects [13] . Moreover, in larger adult animals, nonshivering thermogenesis is negligible and thus can not be infl uenced such as in small animals (for example, mice) with a metabolic rate that is 15-to 20-fold higher than that of humans [9] . Finally, any Na 2 S-related thera peutic eff ect in larger animals was independent of body tempera ture [14] [15] [16] .
Abstract
Whether the hydrogen sulfi de (H 2 S)-induced metabolic depression observed in awake rodents exists in larger species is controversial. Therefore, Derwall and colleagues exposed anesthetized and ventilated sheep to incremental H 2 S concentrations by means of an extracorporeal membrane oxygenator. H 2 S caused pulmonary vasoconstriction and metabolic acidosis at the highest concentration studied. Oxygen uptake and carbon dioxide production remained in the physiological range. The authors concluded that, beyond the eff ect of temperature, H 2 S hardly modifi es metabolism at all. Since the highest H 2 S concentration caused toxic side eff ects (possibly due to an inhibition of mitochondrial respiration), the therapeutic use of inhaled H 2 S should be cautioned.
What is the future of H 2 S in critical care medicine? Th e vascular eff ects of H 2 S are still controversial: Derwall and colleagues [1] found a dose-dependent pulmonary vasocon striction, which at fi rst glance agrees with the hypoxiasensing properties attributed to H 2 S [17] . However, the mixed venous oxygen partial pressure (PO 2 ) was 50 to 55 mm Hg (that is, clearly above the range that induced hypoxic vasoconstriction of isolated pulmonary arteries of cows [17] ). In addition, the pulmonary vascular vasomotor response to H 2 S in vitro showed marked interspecies diff erences, so that any eff ect in the critically ill patient is diffi cult to anticipate [17] . Th e systemic vasomotor eff ect of H 2 S is equally intriguing: endogenous H 2 S is a physiological vasodilator and thus assumes major importance in the control of blood pressure [18] . Derwall and colleagues [1] report that the highest H 2 S concen tration caused marked systemic vasodilation, whereas other authors [11, 16] found that Na 2 S reduced the noradrenaline doses required to achieve hemodynamic targets during reperfusion after porcine aortic balloon occlusion.
Th e appropriate H 2 S dose is also unknown: in the previous large animal studies, a 25-fold range of intravenous Na 2 S infusion rates was used [11, 12, [14] [15] [16] , and, as in the present investigation, higher infusion rates over longer periods of time impaired pulmonary gas exchange [11, 12] . Th e signifi cant meta bolic acidosis affi liated with the highest H 2 S concentra tion deserves particular attention, but unfortunately the authors did not further elucidate this fi nding. It is tempting to speculate that inhibition of mitochodondrial respiration with subsequent reduction of aerobic capacity caused this metabolic acidosis: H 2 S is a well-established inhibitor of the cytochrome C oxidase, and the subtle increase in the respiratory quotient that can be derived from the mean VO 2 and VCO 2 values before and after exposure to 300 parts per million H 2 S, respectively, replicates data reported on the eff ects of H 2 S inhalation in exercising humans [19] . Finally, as the authors themselves acknowledge, the fate of exogenous H 2 S remains unclear: they found, in the eff erent blood of the extracorporeal membrane lung, sulfi de levels that were associated with near-complete inhibition of the respira tory chain in vitro [13] . Th e arterial blood concentrations, however, were in the same range as measured during Na 2 S infusion in swine, in which Na 2 S protected against myocardial [16] and renal [17] ischemia/reperfusion injury.
In conclusion, Derwall and colleagues performed an elegant ovine study to test whether a pharmacological (that is, H 2 S-induced) metabolic depression can be achieved in large animals. While the authors did not fi nd any gross modifi cations of energy expenditure, they observed several intriguing hemodynamic and acid-base eff ects, which confi rm the complex actions of this 'third gaseous mediator' . Abbreviations H 2 S, hydrogen sulfi de; Na 2 S, sodium sulfi de; VCO 2 , carbon dioxide production; VO 2 , oxygen uptake.
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